Ferret animal model of severe fever with thrombocytopenia syndrome phlebovirus for human lethal infection and pathogenesis.
Journal
Nature microbiology
ISSN: 2058-5276
Titre abrégé: Nat Microbiol
Pays: England
ID NLM: 101674869
Informations de publication
Date de publication:
03 2019
03 2019
Historique:
received:
19
05
2018
accepted:
06
11
2018
pubmed:
12
12
2018
medline:
6
6
2019
entrez:
12
12
2018
Statut:
ppublish
Résumé
Severe fever with thrombocytopenia syndrome phlebovirus (SFTSV), listed in the most dangerous pathogens by the World Health Organization, has 12-30% fatality rates with a characteristic thrombocytopenia syndrome. With a majority of clinically diagnosed SFTSV patients older than ~50 years of age, age is a critical risk factor for SFTSV morbidity and mortality. Here, we report an age-dependent ferret model of SFTSV infection and pathogenesis that fully recapitulates the clinical manifestations of human infections. Whereas young adult ferrets (≤2 years of age) did not show any clinical symptoms and mortality, SFTSV-infected aged ferrets (≥4 years of age) demonstrated severe thrombocytopenia, reduced white blood cell counts and high fever with 93% mortality rate. Moreover, a significantly higher viral load was observed in aged ferrets. Transcriptome analysis of SFTSV-infected young ferrets revealed strong interferon-mediated anti-viral signalling, whereas inflammatory immune responses were markedly upregulated and persisted in aged ferrets. Thus, this immunocompetent age-dependent ferret model should be useful for anti-SFTSV therapy and vaccine development.
Identifiants
pubmed: 30531978
doi: 10.1038/s41564-018-0317-1
pii: 10.1038/s41564-018-0317-1
pmc: PMC6548318
mid: NIHMS1022670
doi:
Substances chimiques
Interferons
9008-11-1
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
438-446Subventions
Organisme : NIAID NIH HHS
ID : R01 AI140705
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI129496
Pays : United States
Commentaires et corrections
Type : CommentIn
Références
Vet Res. 2010 Nov-Dec;41(6):61
pubmed: 21188836
J Gen Virol. 2012 Jun;93(Pt 6):1288-93
pubmed: 22357748
Proc Natl Acad Sci U S A. 2012 Jun 19;109(25):10053-8
pubmed: 22665769
Vet Rec. 2012 Sep 1;171(9):218
pubmed: 22859408
PLoS One. 2012;7(7):e41365
pubmed: 22911786
PLoS One. 2013 Apr 29;8(4):e62083
pubmed: 23637969
Emerg Infect Dis. 2013 Nov;19(11):1892-4
pubmed: 24206586
J Infect Dis. 2014 Mar;209(6):816-27
pubmed: 24231186
J Virol. 2014 Feb;88(3):1781-6
pubmed: 24257618
Rev Med Virol. 2014 Mar;24(2):90-102
pubmed: 24310908
J Infect Dis. 2015 Mar 15;211(6):915-25
pubmed: 25326554
Pathol Int. 2014 Nov;64(11):569-75
pubmed: 25329676
Vet Clin North Am Exot Anim Pract. 2015 Jan;18(1):1-8
pubmed: 25421021
Clin Microbiol Infect. 2015 Jul;21(7):614-20
pubmed: 25769426
Virology. 2015 Aug;482:19-27
pubmed: 25817401
Sci Rep. 2015 Nov 18;5:16512
pubmed: 26576844
Sci Rep. 2016 Sep 08;6:33175
pubmed: 27605309
Int J Infect Dis. 2017 May;58:45-51
pubmed: 28249810
Virol Sin. 2017 Feb;32(1):51-62
pubmed: 28251515
Arch Virol. 2017 Aug;162(8):2505-2538
pubmed: 28434098
PLoS Negl Trop Dis. 2017 Sep 22;11(9):e0005893
pubmed: 28937979
Antivir Chem Chemother. 2017 Dec;25(3):83-89
pubmed: 29096526
J Infect Chemother. 2018 Apr;24(4):292-297
pubmed: 29138019
Virol J. 2018 May 30;15(1):97
pubmed: 29848330